{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T10:08:38Z","timestamp":1783850918118,"version":"3.55.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003827","name":"National Research Development and Innovation Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005881","name":"Ministry of Human Capacities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017864","name":"Ministry of Finance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"CONACYT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.bcp.2022.115023","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T11:23:08Z","timestamp":1648466588000},"page":"115023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["sVmKTx, a transcriptome analysis-based synthetic peptide analogue of Vm24, inhibits Kv1.3 channels of human T cells with improved selectivity"],"prefix":"10.1016","volume":"199","author":[{"given":"Agota","family":"Csoti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosby","family":"del Carmen N\u00e1jera Meza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc","family":"Bog\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor","family":"Tajti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor G.","family":"Szanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina B.","family":"Gurrola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor K.","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourival D.","family":"Possani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyorgy","family":"Panyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bcp.2022.115023_b0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.actatropica.2008.05.021","article-title":"Epidemiology of scorpionism: a global appraisal","volume":"107","author":"Chippaux","year":"2008","journal-title":"Acta Trop."},{"issue":"7","key":"10.1016\/j.bcp.2022.115023_b0010","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.toxicon.2009.11.010","article-title":"Mining on scorpion venom biodiversity","volume":"56","author":"Rodr\u00edguez de la Vega","year":"2010","journal-title":"Toxicon"},{"issue":"2-3","key":"10.1016\/j.bcp.2022.115023_b0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0014-5793(00)01239-4","article-title":"Chemical synthesis and characterization of maurocalcine, a scorpion toxin that activates Ca(2+) release channel\/ryanodine receptors","volume":"469","author":"Fajloun","year":"2000","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.bcp.2022.115023_b0020","doi-asserted-by":"crossref","first-page":"C361","DOI":"10.1152\/ajpcell.1993.264.2.C361","article-title":"Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion","volume":"264","author":"DeBin","year":"1993","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bcp.2022.115023_b0025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuropharm.2017.07.002","article-title":"Venom-derived peptide inhibitors of voltage-gated potassium channels","volume":"127","author":"Norton","year":"2017","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.bcp.2022.115023_b0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.tips.2009.12.007","article-title":"Targeting voltage sensors in sodium channels with spider toxins","volume":"31","author":"Bosmans","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"issue":"6000","key":"10.1016\/j.bcp.2022.115023_b0035","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/313316a0","article-title":"Charybdotoxin, a protein inhibitor of single Ca2+-activated K+ channels from mammalian skeletal muscle","volume":"313","author":"Miller","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2022.115023_b0040","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuropharm.2016.10.004","article-title":"Scorpion toxin peptide action at the ion channel subunit level","volume":"127","author":"Housley","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2022.115023_b0045","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.toxicon.2013.07.012","article-title":"Scorpion venom components that affect ion-channels function","volume":"76","author":"Quintero-Hern\u00e1ndez","year":"2013","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/j.bcp.2022.115023_b0050","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1432-1327.1999.00625.x","article-title":"Scorpion toxins specific for Na+-channels","volume":"264","author":"Possani","year":"1999","journal-title":"Eur. J. Biochem."},{"issue":"11","key":"10.1016\/j.bcp.2022.115023_b0055","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0165-6147(99)01398-X","article-title":"A unified nomenclature for short-chain peptides isolated from scorpion venoms: alpha-KTx molecular subfamilies","volume":"20","author":"Tytgat","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.bcp.2022.115023_b0060","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/0041-0101(93)90253-F","article-title":"Peptide T, a novel bradykinin potentiator isolated from Tityus serrulatus scorpion venom","volume":"31","author":"Ferreira","year":"1993","journal-title":"Toxicon"},{"issue":"16","key":"10.1016\/j.bcp.2022.115023_b0065","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1046\/j.1432-1327.2000.01556.x","article-title":"Hadrurin, a new antimicrobial peptide from the venom of the scorpion Hadrurus aztecus","volume":"267","author":"Torres-Larios","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bcp.2022.115023_b0070","article-title":"Transcriptome analysis of the Tityus serrulatus scorpion venom gland","volume":"2","author":"Alvarenga","year":"2012","journal-title":"Open J. Genet."},{"issue":"1","key":"10.1016\/j.bcp.2022.115023_b0075","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2164-10-290","article-title":"Transcriptome analysis of the venom gland of the scorpion Scorpiops jendeki: implication for the evolution of the scorpion venom arsenal","volume":"10","author":"Ma","year":"2009","journal-title":"BMC Genomics"},{"issue":"1","key":"10.1016\/j.bcp.2022.115023_b0080","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2164-8-119","article-title":"Transcriptome analysis of the venom gland of the Mexican scorpion Hadrurus gertschi (Arachnida: Scorpiones)","volume":"8","author":"Schwartz","year":"2007","journal-title":"BMC Genomics"},{"issue":"2","key":"10.1016\/j.bcp.2022.115023_b0085","doi-asserted-by":"crossref","first-page":"e0117188","DOI":"10.1371\/journal.pone.0117188","article-title":"Transcriptome analysis of scorpion species belonging to the Vaejovis genus","volume":"10","author":"Quintero-Hernandez","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2022.115023_b0090","doi-asserted-by":"crossref","first-page":"114146","DOI":"10.1016\/j.bcp.2020.114146","article-title":"The voltage-gated potassium channel KV1.3 as a therapeutic target for venom-derived peptides","volume":"181","author":"Tajti","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2022.115023_b0095","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1172\/JCI16921","article-title":"The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS","volume":"111","author":"Wulff","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"46","key":"10.1016\/j.bcp.2022.115023_b0100","doi-asserted-by":"crossref","first-page":"17414","DOI":"10.1073\/pnas.0605136103","article-title":"Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases","volume":"103","author":"Beeton","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.bcp.2022.115023_b0105","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1124\/mol.104.008193","article-title":"Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases","volume":"67","author":"Beeton","year":"2005","journal-title":"Mol. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2022.115023_b0110","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.it.2004.09.002","article-title":"Looking through ion channels: recharged concepts in T-cell signaling","volume":"25","author":"Panyi","year":"2004","journal-title":"Trends Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2022.115023_b0115","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3390\/ijms21051568","article-title":"Periodic Membrane Potential and Ca(2+) Oscillations in T Cells Forming an Immune Synapse","volume":"21","author":"Papp","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.bcp.2022.115023_b0120","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.2174\/138161206777585120","article-title":"K+ channel blockers: novel tools to inhibit T cell activation leading to specific immunosuppression","volume":"12","author":"Panyi","year":"2006","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.bcp.2022.115023_b0125","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1124\/mol.112.078006","article-title":"Vm24, a natural immunosuppressive peptide, potently and selectively blocks Kv1.3 potassium channels of human T cells","volume":"82","author":"Varga","year":"2012","journal-title":"Mol. Pharmacol."},{"issue":"19","key":"10.1016\/j.bcp.2022.115023_b0130","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1021\/bi300060n","article-title":"Structure, function, and chemical synthesis of Vaejovis mexicanus peptide 24: a novel potent blocker of Kv1.3 potassium channels of human T lymphocytes","volume":"51","author":"Gurrola","year":"2012","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.bcp.2022.115023_b0135","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/19336950.2020.1859753","article-title":"Immunomagnetic separation is a suitable method for electrophysiology and ion channel pharmacology studies on T cells","volume":"15","author":"Tajti","year":"2021","journal-title":"Channels (Austin)"},{"issue":"4","key":"10.1016\/j.bcp.2022.115023_b0140","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1124\/mol.104.007187","article-title":"Anuroctoxin, a new scorpion toxin of the alpha-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes","volume":"67","author":"Bagdany","year":"2005","journal-title":"Mol. Pharmacol."},{"issue":"9","key":"10.1016\/j.bcp.2022.115023_b0145","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.bcp.2008.08.018","article-title":"A selective blocker of Kv1.2 and Kv1.3 potassium channels from the venom of the scorpion Centruroides suffusus suffusus","volume":"76","author":"Corzo","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2022.115023_b0150","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0026-895X(25)10594-4","article-title":"Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines","volume":"45","author":"Grissmer","year":"1994","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115023_b0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s002320010033","article-title":"Effects of toxins Pi2 and Pi3 on human T lymphocyte Kv1.3 channels: the role of Glu7 and Lys24","volume":"179","author":"P\u00e9ter Jr.","year":"2001","journal-title":"J Membr. Biol."},{"issue":"5","key":"10.1016\/j.bcp.2022.115023_b0160","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1016\/S0006-3495(03)70023-X","article-title":"Stimulatory action of internal protons on Slo1 BK channels","volume":"84","author":"Avdonin","year":"2003","journal-title":"Biophys. J."},{"issue":"4","key":"10.1016\/j.bcp.2022.115023_b0165","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1085\/jgp.102.4.601","article-title":"Calcium-activated potassium channels in resting and activated human T lymphocytes. Expression levels, calcium dependence, ion selectivity, and pharmacology","volume":"102","author":"Grissmer","year":"1993","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.bcp.2022.115023_b0170","doi-asserted-by":"crossref","first-page":"e00594","DOI":"10.7554\/eLife.00594","article-title":"Structure of a pore-blocking toxin in complex with a eukaryotic voltage-dependent K(+) channel","volume":"2","author":"Banerjee","year":"2013","journal-title":"Elife"},{"issue":"38","key":"10.1016\/j.bcp.2022.115023_b0175","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1703952114","article-title":"Discovery of peptide ligands through docking and virtual screening at nicotinic acetylcholine receptor homology models","volume":"114","author":"Leffler","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"39","key":"10.1016\/j.bcp.2022.115023_b0180","doi-asserted-by":"crossref","first-page":"13749","DOI":"10.1073\/pnas.0506346102","article-title":"Replica exchange with solute tempering: a method for sampling biological systems in explicit water","volume":"102","author":"Liu","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"30","key":"10.1016\/j.bcp.2022.115023_b0185","doi-asserted-by":"crossref","first-page":"9431","DOI":"10.1021\/jp204407d","article-title":"Replica exchange with solute scaling: a more efficient version of replica exchange with solute tempering (REST2)","volume":"115","author":"Wang","year":"2011","journal-title":"J. Phys. Chem. B"},{"issue":"1","key":"10.1016\/j.bcp.2022.115023_b0190","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J. Chem. Theory Comput."},{"issue":"7","key":"10.1016\/j.bcp.2022.115023_b0195","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.cell.2015.06.002","article-title":"Crystal Structure of Antagonist Bound Human Lysophosphatidic Acid Receptor 1","volume":"161","author":"Chrencik","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2022.115023_b0200","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7387","article-title":"Glycopeptide analogues of PSGL-1 inhibit P-selectin in vitro and in vivo","volume":"6","author":"Krishnamurthy","year":"2015","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.bcp.2022.115023_b0205","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1002\/prot.24694","article-title":"Physics-based enzyme design: predicting binding affinity and catalytic activity","volume":"82","author":"Sirin","year":"2014","journal-title":"Proteins"},{"issue":"12","key":"10.1016\/j.bcp.2022.115023_b0210","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/ar000033j","article-title":"Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models","volume":"33","author":"Kollman","year":"2000","journal-title":"Acc. Chem. Res."},{"issue":"16","key":"10.1016\/j.bcp.2022.115023_b0215","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","article-title":"End-Point Binding Free Energy Calculation with MM\/PBSA and MM\/GBSA: Strategies and Applications in Drug Design","volume":"119","author":"Wang","year":"2019","journal-title":"Chem. Rev."},{"issue":"5","key":"10.1016\/j.bcp.2022.115023_b0220","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"issue":"4","key":"10.1016\/j.bcp.2022.115023_b0225","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0022-2836(03)00610-7","article-title":"Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes","volume":"330","author":"Gohlke","year":"2003","journal-title":"J. Mol. Biol."},{"issue":"9","key":"10.1016\/j.bcp.2022.115023_b0230","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1021\/acs.jcim.7b00347","article-title":"Statistical Analysis on the Performance of Molecular Mechanics Poisson-Boltzmann Surface Area versus Absolute Binding Free Energy Calculations: Bromodomains as a Case Study","volume":"57","author":"Aldeghi","year":"2017","journal-title":"J. Chem. Inf. Model."},{"issue":"4","key":"10.1016\/j.bcp.2022.115023_b0235","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0006-3495(93)81200-1","article-title":"Mechanism of charybdotoxin block of a voltage-gated K+ channel","volume":"65","author":"Goldstein","year":"1993","journal-title":"Biophys. J."},{"issue":"8","key":"10.1016\/j.bcp.2022.115023_b0240","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00424-016-1851-4","article-title":"7DHC-induced changes of Kv1.3 operation contributes to modified T cell function in Smith-Lemli-Opitz syndrome","volume":"468","author":"Balajthy","year":"2016","journal-title":"Pflugers Arch."},{"issue":"1","key":"10.1016\/j.bcp.2022.115023_b0245","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-018-0257-7","article-title":"Kv1.3 channel blockade with the Vm24 scorpion toxin attenuates the CD4(+) effector memory T cell response to TCR stimulation","volume":"16","author":"Veytia-Bucheli","year":"2018","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.bcp.2022.115023_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/750203","article-title":"Placing ion channels into a signaling network of T cells: from maturing thymocytes to healthy T lymphocytes or leukemic T lymphoblasts","volume":"2015","author":"Dobrovinskaya","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"7","key":"10.1016\/j.bcp.2022.115023_b0255","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1074\/jbc.272.7.4302","article-title":"On the convergent evolution of animal toxins. Conservation of a diad of functional residues in potassium channel-blocking toxins with unrelated structures","volume":"272","author":"Dauplais","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2022.115023_b0260","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/0896-6273(94)90452-9","article-title":"The charybdotoxin receptor of a Shaker K+ channel: peptide and channel residues mediating molecular recognition","volume":"12","author":"Goldstein","year":"1994","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.bcp.2022.115023_b0265","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0041-0101(95)00013-C","article-title":"Characterization of a potassium channel toxin from the Caribbean Sea anemone Stichodactyla helianthus","volume":"33","author":"Casta\u00f1eda","year":"1995","journal-title":"Toxicon"},{"issue":"4","key":"10.1016\/j.bcp.2022.115023_b0270","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nsb0496-317","article-title":"Solution structure of ShK toxin, a novel potassium channel inhibitor from a sea anemone","volume":"3","author":"Tudor","year":"1996","journal-title":"Nat. Struct. Biol."},{"issue":"25","key":"10.1016\/j.bcp.2022.115023_b0275","doi-asserted-by":"crossref","first-page":"18866","DOI":"10.1016\/S0021-9258(17)46707-X","article-title":"Purification, characterization, and biosynthesis of margatoxin, a component of Centruroides margaritatus venom that selectively inhibits voltage-dependent potassium channels","volume":"268","author":"Garcia-Calvo","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2022.115023_b0280","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.toxicon.2014.05.002","article-title":"Margatoxin is a non-selective inhibitor of human Kv1.3 K+ channels","volume":"87","author":"Bartok","year":"2014","journal-title":"Toxicon"},{"issue":"Pt 1","key":"10.1016\/j.bcp.2022.115023_b0285","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/BJ20041379","article-title":"K+ channel types targeted by synthetic OSK1, a toxin from Orthochirus scrobiculosus scorpion venom","volume":"385","author":"Mouhat","year":"2005","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.bcp.2022.115023_b0290","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/bj3280321","article-title":"A four-disulphide-bridged toxin, with high affinity towards voltage-gated K+ channels, isolated from Heterometrus spinnifer (Scorpionidae) venom","volume":"328","author":"Lebrun","year":"1997","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.bcp.2022.115023_b0295","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.toxicon.2009.05.023","article-title":"Tst26, a novel peptide blocker of Kv1.2 and Kv1.3 channels from the venom of Tityus stigmurus","volume":"54","author":"Papp","year":"2009","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.bcp.2022.115023_b0300","article-title":"A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases","volume":"4","author":"Rashid","year":"2015","journal-title":"Sci. Rep."},{"issue":"29","key":"10.1016\/j.bcp.2022.115023_b0305","doi-asserted-by":"crossref","first-page":"27093","DOI":"10.1074\/jbc.M413626200","article-title":"A variable residue in the pore of Kv1 channels is critical for the high affinity of blockers from sea anemones and scorpions","volume":"280","author":"Gilquin","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2022.115023_b0310","doi-asserted-by":"crossref","DOI":"10.1038\/srep18397","article-title":"An engineered scorpion toxin analogue with improved Kv1.3 selectivity displays reduced conformational flexibility","volume":"5","author":"Bartok","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bcp.2022.115023_b0315","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1080\/14712598.2017.1346606","article-title":"Treating autoimmune disorders with venom-derived peptides","volume":"17","author":"Shen","year":"2017","journal-title":"Expert Opin. Biol. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2022.115023_b0320","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1002\/med.21800","article-title":"Discovery of KV 1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges","volume":"41","author":"Gubi\u010d","year":"2021","journal-title":"Med. Res. Rev."},{"issue":"49","key":"10.1016\/j.bcp.2022.115023_b0325","doi-asserted-by":"crossref","first-page":"32697","DOI":"10.1074\/jbc.273.49.32697","article-title":"ShK-Dap22, a potent Kv1.3-specific immunosuppressive polypeptide","volume":"273","author":"Kalman","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2022.115023_b0330","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1124\/mol.105.017210","article-title":"Pharmacological profiling of Orthochirus scrobiculosus toxin 1 analogs with a trimmed N-terminal domain","volume":"69","author":"Mouhat","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115023_b0335","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbrc.2014.03.101","article-title":"Unusual binding mode of scorpion toxin BmKTX onto potassium channels relies on its distribution of acidic residues","volume":"447","author":"Chen","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.bcp.2022.115023_b0340","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.toxicon.2003.11.029","article-title":"Molecular basis of alpha-KTx specificity","volume":"43","author":"Giangiacomo","year":"2004","journal-title":"Toxicon"},{"issue":"27","key":"10.1016\/j.bcp.2022.115023_b0345","doi-asserted-by":"crossref","first-page":"19058","DOI":"10.1074\/jbc.M802054200","article-title":"Structural basis of a potent peptide inhibitor designed for Kv1.3 channel, a therapeutic target of autoimmune disease","volume":"283","author":"Han","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2022.115023_b0350","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3390\/md13010529","article-title":"Development of highly selective Kv1.3-blocking peptides based on the sea anemone peptide ShK","volume":"13","author":"Pennington","year":"2015","journal-title":"Mar. Drugs"},{"issue":"7","key":"10.1016\/j.bcp.2022.115023_b0355","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1357-2725(00)00016-9","article-title":"CD154 (CD40 ligand)","volume":"32","author":"Sch\u00f6nbeck","year":"2000","journal-title":"Int. J. Biochem. Cell. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115023_b0360","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1158\/0008-5472.CAN-16-2372","article-title":"Kv1.3 Channels Mark Functionally Competent CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Cancer","volume":"77","author":"Chimote","year":"2017","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2022.115023_b0365","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev-immunol-032414-112212","article-title":"Ion channels in innate and adaptive immunity","volume":"33","author":"Feske","year":"2015","journal-title":"Annu. Rev. Immunol."},{"issue":"24","key":"10.1016\/j.bcp.2022.115023_b0370","doi-asserted-by":"crossref","first-page":"13942","DOI":"10.1073\/pnas.241497298","article-title":"Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis","volume":"98","author":"Beeton","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2022.115023_b0375","doi-asserted-by":"crossref","DOI":"10.1590\/1678-9199-jvatitd-1481-18","article-title":"Scorpion toxins targeting Kv1.3 channels: insights into immunosuppression","volume":"25","author":"Oliveira","year":"2019","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222001174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222001174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:35:52Z","timestamp":1757770552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295222001174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":75,"alternative-id":["S0006295222001174"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115023","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"sVmKTx, a transcriptome analysis-based synthetic peptide analogue of Vm24, inhibits Kv1.3 channels of human T cells with improved selectivity","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115023"}}